If your right he did a terrible job with his other company HNSO .0005 that stock tanked badly after he took over.
Healthnostics Provides Corporate Update
Tuesday August 5, 7:16 am ET
BETHESDA, Md.--(BUSINESS WIRE)--Healthnostics, Inc. (PINK SHEETS: HNSO - News), a medical and biotechnology analytics company, is pleased to provide the following update report regarding the Company’s development and progress.
ADVERTISEMENT
Trading in Healthnostics Stock
The recent decrease in our stock price over the past months has occurred even though the value of our company has increased as described in recent news releases by Healthnostics. Our opinion is the Company’s stock is undervalued based upon our assets and the performance of our recent acquisition, GMD, Inc. Currently there are 1,956,538,155 shares outstanding, of which approximately 1,200,000,000 shares were issued in conjunction with the GMD transaction. The float is currently approximately 440,000,000 shares. Long-term insiders hold over 250,000,000 shares in the float.
The current market selling of our stock has not been undertaken by the Company nor the insiders.
Strategy
The Company’s strategy is to leverage, build or acquire compatible healthcare technologies that will create valuable business offerings from us in the healthcare and biotechnology information technology market. To that end Healthnostics acquired a major interest in GMD, Inc. a nationwide durable medical equipment provider specializing in direct to consumer diabetic supplies. The company continues to evaluate new acquisition and investment opportunities that are compatible with our strategy.
GMD, Inc.
GMD’s fiscal year ended June 30, 2008. Previously the Company announced that GMD was on target for record revenues of nearly $10 million on a profitable basis. The actual results will be announced after completion of the year-end closing.
MedBioWeb Corp.
MedBioWeb’s medical and biotechnology professional portal MedBioWorld.com continues to draw praise from its users and has an increasing user base. New advertising and partner affiliate programs are underway that have increased revenue.
Healthnostics is in the process of restructuring the MedBioWeb Corp. spin-off and preparing a new registration statement. Previously, Healthnostics announced that the Company had filed a registration statement to spin-off MedBioWeb Corp., into a new, fully reporting company.
Clinical Software Systems
MedGuardian, which addresses critical quality improvement issues facing hospitals today, continues to be successfully marketed to hospital associations, government and private sector hospitals generating new and viable future sales opportunities. Healthnostics’ target market for MedGuardian is the 4,200 small to medium sized acute care hospitals that constitute the majority of hospitals in the U.S.
For further information please visit Healthnostics www.healthnostics.com, MedBioWorld www.medbioworld.com, MedNets www.mednets.com, and FamilyMedicalNet www.familymedicalnet.com.
This press release may contain certain statements that are not descriptions of historical information, but are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Exchange Act of 1934. These forward-looking statements refer to matters that involve risks and uncertainties. Such statements reflect management's current views and are based on certain assumptions. Actual results could differ materially from the assumptions currently anticipated.
Contact:
Healthnostics, Inc.
Michael Black, 410-295-3388
contact@healthnostics.com
AI
